SCHEMBL3789280

SCHEMBL3789280

Cc1c(CN)cccc1-c1cccc(CN)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 2/20 0.49
CD274 Q9NZQ7 5/20 0.47
PDCD1 Q15116 2/20 0.47
DPP4 P27487 1/20 0.44
NOS1 P29475 2/20 0.40
NOS2 P35228 2/20 0.40
NOS3 P29474 1/20 0.40
PNMT P11086 1/20 0.40
ENPP2 Q13822 1/20 0.40
CSNK2A1 P68400 2/20 0.40
CSNK2A2 P19784 1/20 0.40
CSNK2B P67870 1/20 0.40
CSNK2A3 Q8NEV1 1/20 0.40
CFD P00746 3/20 0.39
PLG P00747 1/20 0.39
PLAU P00749 1/20 0.39
F11 P03951 1/20 0.39
KLKB1 P03952 1/20 0.39
F7 P08709 1/20 0.39
TPSB2 P20231 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3784785 0.84 CD274 (0.53) CD274PDCD1DPP4CSNK2A1CSNK2A2
SCHEMBL3781449 0.84 DPP4 (0.64) HTR7DPP4NOS1NOS2NOS3
SCHEMBL3793203 0.82 CD274 (0.69) CD274PDCD1DPP4PNMTTAAR1
SCHEMBL3788421 0.79 HTR7 (0.75) HTR7NOS1NOS2NOS3PNMT
SCHEMBL3784856 0.78 HTR7 (0.44) HTR7DPP4NOS1NOS2NOS3
SCHEMBL3788481 0.78 HTR7 (0.44) HTR7DPP4NOS1NOS2NOS3
SCHEMBL3786468 0.77 HTR7 (0.50) HTR7NOS1NOS2NOS3PNMT
SCHEMBL3789721 0.76 HTR7 (0.57) HTR7CD274DPP4NOS1NOS2
SCHEMBL27649924 0.76 LOXL2 (0.58) HTR7DPP4PNMTENPP2CSNK2A1
SCHEMBL14601394 0.76 HTR7 (0.52) HTR7DPP4CSNK2A1CSNK2A2CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 HTR7 1295/4885CD274 1253/4885PDCD1 465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.